NephroGenex, Inc. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/62880d32-503e-41ac-b459-f1118bf9b728/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-22.9M | 2015-01-01 – 2015-12-31 | evidence 0001338095-16-000103 |
| FY 2014 | $-16.8M | 2014-01-01 – 2014-12-31 | evidence 0001338095-15-000016 |
| FY 2013 | $-42.7M | 2004-05-25 – 2014-03-31 | evidence 0001104659-14-038337 |
| FY 2012 | $-2.9M | 2012-01-01 – 2012-12-31 | evidence 0001104659-14-038337 |
| FY 2011 | $-1.9M | 2011-01-01 – 2011-12-31 | evidence 0001104659-14-038337 |
| FY 2010 | $-5.9M | 2010-01-01 – 2010-12-31 | evidence 0001104659-14-038337 |
| FY 2009 | $-7.5M | 2009-01-01 – 2009-12-31 | evidence 0001104659-14-038337 |
| FY 2008 | $-6.7M | 2008-01-01 – 2008-12-31 | evidence 0001104659-14-038337 |
| FY 2007 | $-7.6M | 2007-01-01 – 2007-12-31 | evidence 0001104659-14-038337 |
| FY 2006 | $-1.3M | 2006-01-01 – 2006-12-31 | evidence 0001104659-14-038337 |
| FY 2005 | $-688.9k | 2005-01-01 – 2005-12-31 | evidence 0001104659-14-038337 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).